Peer-reviewedCC BY-NC-NDMolecular therapy. Advances
Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight
4 affiliations
- 1Ultragenyx Pharmaceutical Inc., Novato, CA, USA
- 2Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 3Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- 4McGill University – Montreal Children’s Hospital, Montreal, QC, Canada
Related
- Target Discovery and Drug Intervention in Inflammatory Diseases: A Paradigm Shift from Mechanistic Dissection to Precision Therapy
- Enhanced exosome biomanufacturing, precision isolation, and advanced engineering: toward mechanistic regulation and biomaterial integration for osteoarthritis therapy
- RNA-binding proteins in tumor lipid metabolic reprogramming: from mechanistic understanding to targeted therapy
- Secondary Intracranial Hypertension During ATRA/ATO Therapy in High-Risk Acute Promyelocytic Leukemia: A Case Report and Practical Management Framework.
- Rare Case Report: Therapy-Related Acute Promyelocytic Leukemia (t-APL) in a Young Non-HBV Female After TACE Plus Sintilimab-Lenvatinib for HCC — A Clinical Alert and Literature Review
BibTeX
@article{sullivan2026management,
title = {{Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight}},
author = {Barbara A. Sullivan and Richard Collis and Rhea Cahayag and Hector M. Lopez and Mary Grace Baker and Emil D. Kakkis and Syeda Rahman and Danny Bega and Margo Sheck Breilyn and John J. Mitchell and Andrew A. Grimm},
journal = {Molecular therapy. Advances},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13675699},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight
AU - Barbara A. Sullivan
AU - Richard Collis
AU - Rhea Cahayag
AU - Hector M. Lopez
AU - Mary Grace Baker
AU - Emil D. Kakkis
AU - Syeda Rahman
AU - Danny Bega
AU - Margo Sheck Breilyn
AU - John J. Mitchell
AU - Andrew A. Grimm
PY - 2026
DA - 2026/09/04
JO - Molecular therapy. Advances
UR - https://europepmc.org/article/PMC/PMC13675699
SN - 3117-387X
ER -